Magnetoencephalography Market Research, Segmentation, Key Players Analysis and Forecast to 2033 | FMI

 The Magnetoencephalography Market revenues were estimated at US$ 273 Million in 2022 and is anticipated to grow at a CAGR of 5.4% from 2023 to 2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 485.2 Million.

MEG scanners have been found to be one of the common tools for diagnosing epilepsy, brain lesions, emotional states, pain recognition, and other complex neurological disorders. MEG is based on using belief neuromagnetic impulses do not distort as they pass through the skull and scalp.

Get a Full PDF Sample Copy of the Latest Reports @ https://www.futuremarketinsights.com/reports/sample/rep-gb-16555

Scanners have been around for decades, but recent developments in computer power and hardware have sparked renewed interest in them. MEG scanners are widely used around the world, and their number of users is growing. Furthermore, increased research and development efforts are expected to enhance the market for magnetoencephalography scanners from 2023 to 2033.

The HSE Institute for Cognitive Neuroscience, for example, has developed a new approach for processing MEG data that allows for more exact cortical activation zone identification. In both basic clinical and scientific practice, the approach can aid in the diagnosis of a variety of neurological illnesses and the preparation of patients for brain surgery.

Magnetoencephalography is a medical test that analyses the magnetic fields created by the electrical currents in the human brain without piercing or incision into the body. This non-invasive medical test is critical for mapping brain function and pinpointing the origins of epileptic episodes. It is the most advanced way of analyzing the brain's active functioning using an electromagnetic recording and evaluation process.

With a CAGR of over 5%, Magnetoencephalic imaging revenue in North America is expected to surge at a significant pace. The presence of a large number of market rivals in the region, as well as the high frequency with which new products are released contribute towards the regional market growth. Furthermore, in the United States, patient outcomes and safety are of paramount importance, wherein various projects have been introduced to improve healthcare quality and results.

Competitive Analysis

  • Compumedics Limited
  • Croton Healthcare
  • Ricoh USA, Inc.
  • CTF MEG INTERNATIONAL SERVICES LP
  • FieldLine Inc.

A few recent developments in the Magnetoencephalography Market are as follows:

  • In July 2018, York Instruments Ltd. purchased Elekta's magnetoencephalography business.
  • In November 2018, Leti introduced a MEG scanning gadget, also known as a wearable brain scanner or MEG helmet. It is designed for improved epilepsy and brain tumor diagnosis.

Gain complete access to the report @ https://www.futuremarketinsights.com/reports/magnetoencephalography-market

Market Segments Covered in Magnetoencephalography Industry Analysis

By Application:

  • Clinical
    • Dementia
    • Autism
    • Schizophrenia
    • Multiple Sclerosis
    • Stroke
    • Epilepsy
    • Others
  • Research

By End-use:

  • Hospitals
  • Imaging Centes
  • Academic and research institutes

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more

Clostridium Diagnostics Market in US is anticipated to secure a market value worth US$ 2.7 Billion by 2032 | FMI

Image
  The global Clostridium Diagnostics Market is expected to grow at a CAGR of 12.2% during the forecast period, from US$ 2.5 billion in 2022 to US$ 7.8 billion by 2032. The market grew at a CAGR of 13.6% between 2015 and 2021. The rising prevalence of clostridium-related diseases, as well as increased campaigns to educate people about the condition, are driving the market growth. To learn more about this report @ https://www.futuremarketinsights.com/reports/clostridium-diagnostics-market here has been an increased focus of players in the market to offer vaccines, which can augment the market size in the forecast period. For instance, in March 2022, Japan launched a new center, with a budget of US$ 1.6 Billion, to support vaccine and drug projects as a part of a larger scheme to tackle infectious diseases. SCARDA will be in charge of establishing a flagship R&D site for innovative collaborations and controlling funds for R&D projects. Awareness camp...
Read more